A Message from our CEO:
It is hard to believe that over a year has passed since we sold our Pharma consulting assets to IMS Health. Our roots in services continue to serve us well in the software game, as many of our core competencies translate directly. Skura strives to drive maximum customer value through our products.
In October 2008, we sold our pharmaceutical consulting business to IMS Health in an asset sale. This allowed us to further invest in the SFX suite of products and solidify our position in the market as a technology company. Since then, Skura launched the industry’s first fully outsourced Channel Mix Optimization solution, gained new customers in medical devices and high technology, and now leads the market in pharmaceutical CLM.
With our early success with SFX in the pharmaceutical industry, Skura gained recognition from leading analyst firms such as Gartner group, and also acquired five of the top ten Pharma companies as customers.
Long gone are the days when SFX was considered “too integrated to Siebel”. Today SFX is successfully integrated with Salesforce.com, Outlook, Dendrite, Veeva, Oracle on Demand and of course Siebel. And we have more up our sleeves this year! This includes tight integration with a few more household names (we can’t get too specific). However, one is a three letter word; starts with S and ends with P.
Skura manages to lead the market through innovation as we compete in a pharmaceutical vertical with one competitor who is aged and litigious, and another who is more of a banana-bruising middleman. With the SFX cloud solution, we bring this technology to new verticals, and expect to take on more Web 2.0 type companies that rival in these spaces.
Through innovation, a fresh approach, and further investment in the SFX technology, you will see Skura lead the way in Content Meets Customer EVERYWHERE!